Harrow Health Inc (HROW) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Harrow Health Inc (US:HROW), trading at 38.94. In 2025, Harrow Health Inc generated $272.30 Million in revenue and $42.98 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Harrow Health Inc is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 38.94
- Recent Revenue (2025): $272.30 Million
- Free Cash Flow (2025): $42.98 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.